Dr. Sami Alasfar, MD

Dr. Alasfar practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Alasfar's NPI, 1447489000, was assigned on July 4, 2009. Dr. Alasfar graduated from Damascus University Faculty of Medicine in 2008. Dr. Alasfar holds Arizona license 65819.

Dr. Alasfar's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Alasfar's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. Dr. Alasfar is also affiliated with St. Luke's Boise Medical Center. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Alasfar to 3 more hospitals, 1 home health agency and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alasfar practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Alasfar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Alasfar is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Alasfar's licenses on file in 7 states: Arizona, Florida, California, Hawaii, Maryland, North Carolina and Pennsylvania.

CMS data shows 547 Medicare services from Dr. Alasfar across 6 procedure codes in 2024, for 266 Medicare patients. Medicare paid $55,121 for them.

CMS counts 266 Medicare patients who saw Dr. Alasfar in 2024. The largest group is under 65, with 139 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 6.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alasfar's median patient age at 56, with 42% women.

In 2024, Dr. Alasfar wrote 658 Medicare Part D claims for 203 patients. 94% of them were for generic drugs. CMS names the drug for 494 of them, across 13 drugs with 11 or more claims each, at $30,980 in total drug cost. In 2023, CMS named 774 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Alasfar for performance year 2024, reported as part of a group. Dr. Alasfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alasfar as offering telehealth.

Dmand AI links 34 papers to Dr. Alasfar, published from 2016 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Kidney Transplantation, Kidney Failure, Chronic and Tissue Donors. Dr. Alasfar has published most often in Transplant Direct. Dr. Alasfar's most frequent co-authors are Bonnie Elizabeth Lonze, MD, PhD, Sumit Mohan, MD and Lina Murad, MD.

CMS Open Payments shows 17 general payments to Dr. Alasfar from 4 drug and device companies from 2018 to 2024. Speaker and faculty fees make up the largest share, 44% of the total. Roche Diagnostics Corporation paid the most, $6,168.

Dr. Alasfar graduated from Damascus University Faculty of Medicine in 2008. Dr. Alasfar is a member of ASN.

Dr. Alasfar is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.